422 results about "Cerebral Thrombus" patented technology

The Edaravone injection of the present invention is a kind of free radical eliminating medicine to treat acute cerebral infarction. It is injection prepared with Edaravone, additive and solvent and in the form of sterilized solution, emulsion or suspension. It may be small capacity sterilized injection, great capacity sterilized injection, bacteria-free powder preparation for injection, freeze dried powder preparation for injection, sterilized suspension injection or sterilized emulsion injection.

The invention provides a method for the passive motion of human hand, upper limb and lower limb. The hand passive motion is to put air bag below palm and make hand on it open and contract passively by aerating and degassing the air bad. The extension of upper limb and lower limb is to select proper extension points on upper and lower limbs, and realizes passive exercises around shoulder joint or hip joint through extension rope's motion. The invention can increase exercise amount for hand, upper limb and lower limb, especially suitable for patients with cerebral thrombus. It can help them to recovery and prevent further limb atrophy.

The invention relates to the technical field of medical apparatus and instruments, in particular to a novel cerebral thrombus removal device and a method for removing a thrombus by using the device. The cerebral thrombus removal device includes a stent and a transportation system connected with the near end of the stent, the stent is of a self-expansion pipe network structure formed through mutualconnection of multiple mesh units, the surface of the stent is curved in a wave shape, the stent is transported to the vascular embolism position of an intracranial great vessel through the transportation system, the stent of the pipe network structure is unfolded through self-expansion, and the thrombus is captured. The surface of the stent is arranged to be curved in a wave shape, so that the contact area of the surface of the stent and a vessel wall is small, the metal coverage is low, in the process of thrombus removal, damage to the intima of the vessel is less, friction between the thrombus and the vessel wall is reduced at the same time, and therefore the thrombus is easy to remove and maintained to be relatively integrated to prevent thrombus debris from entering the far end or anormal vessel; the thrombus can be removed fast, and the stability of thrombus removal is enhanced.

The invention discloses a compound with thrombolytic activity as well as a preparation method and an application as the thrombolytic agent thereof. The 2-nitrogen or the 3-carboxyl of cyclized dopa is respectively coupled or latticed with H-Ala-Arg-Pro-Ala-Lys-OH, H-Pro-Ala-Lys-OH, H-Arg-Pro-Ala-Lys-OH, H-Gly-Arg-Pro-Ala-Lys-OH or H-Gln-Arg-Pro-Ala-Lys-OH to obtain the compound. The thrombolytic activity of the compound is evaluated by adopting the model of artery-vein bypass cannula thrombus in rats, and the experimental result shows that the compound has the excellent thrombolytic activity and can be clinically used as the thrombolytic agent. The therapeutic action of the compound to the cerebral infarction is further evaluated by adopting the model of cerebral thrombus in rats, and theexperimental result shows that the compound has the excellent brain tissue protection action and can be clinically used as the thrombolytic agent.

The invention discloses a Chinese medicine used for treating cerebral thrombosis, which solves the problems of long therapeutic course, slow action and unable to cure of the existing drugs used for treating cerebral thrombosis. The Chinese medicine consists of the oral drug and drug for external application, wherein, the oral drug is made from long-nosed pit viper, ground beetle, earthworm, scorpion, gastrodia tuber, eucommia bark, mugwort leaf, ledebouriella, shrub chastetree fruit, uncaria, pulp of dogwood fruit, epimedium herb, Szechwan lovage rhizome, dansen root, radix isatidis, artemisia capillaries, herba taxilli, lycium berry, ark shell, Endothelium Corneum Gigeriae Galli, edicated leaven, malt, liquorice, fleece-flower root, honeysuckle, dandelion, herba violae, Chinese wolfberry root-bark, root of pseudo-ginseng and flos sophorae, and the drug for external application is made from pangolin, unprocessed radix aconiti, dandelion, herba violae, dyers woad leaf and fistular onion stalk. The Chinese medicine has the effective rate of 100%, and has the advantages of little side and toxic effect, short course of treatment, quick action, high curative ratio, no relapse after being cured and no other drugs needed for adjuvant therapy.

The present invention relates to the construction of recombinant glucokinase (Sak) and the preparation process of the expression product, and belongs to the field of biotechnology. The Sak of the present invention is Sak derivative with 15 deletion amino acid residues in the N end and comprising 121 amino acids. The modified Sak gene is expressed effectively in colibacillus with expression level 10 % higher than mature glucokinase expression amount and specific activity about 20 % higher than that of mature glucokinase. The separated and purified single component Sak product has expression product with small molecular weight, high specificity and fast thrombolytic speed. The present invention is suitable for industrial production and may be used in prevention and treatment of acute myocardial infarction, cerebral thrombus and other acute thrombotic diseases.

The invention belongs to the technical field of traditional Chinese medicines and in particular relates to a traditional Chinese medicine preparation for adjusting hypertension, hyperlipemia and hyperglycemia. The traditional Chinese medicine preparation is prepared from the following components in parts by weight: 8-20 parts of apium graveolens, 8-20 parts of roots of red-rooted salvia, 5-15 parts of sanchi flowers, 10-30 parts of red rhodobryum, 10-30 parts of roots of kudzu vines, 5-15 parts of anoectochilus formosanus, 5-15 parts of radix cynanchi bungei, 5-15 parts of dendrobe and 20-30 parts of sweet potato leaves. The traditional Chinese medicine preparation is obtained by combining the multi-year clinical experience summary of the investor through repeated experiments on the basis of the secret prescription handed down from ancestors, so that the preparation has a special curative effect on the refractory hypertension, hyperlipemia and hyperglycemia. By scientifically combining the plurality of drugs and compressively applying the preparation, the active ingredients of the drug can quickly enter blood circulation, so that blood cholesterol is lowered, thrombogenesis is blocked, coronary artery is expanded, blood flow volume is increased, myocardial ischemia tolerance is improved, cerebral infarction is improved and damaged cranial nerves are recovered, and therefore, patients with hypertension, hyperlipemia and hyperglycemia are quickly recovered. The traditional Chinese medicine preparation disclosed by the invention has the special curative effect to hypertension, hyperlipemia, diabetes mellitus, brain atrophy, cerebral thrombosis, coronary heart disease, cerebral arteriosclerosis and sequela of apoplexy. Moreover, the traditional Chinese medicine preparation is quick to become effective, short in treatment course, high in cure rate and small in expense.